ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

This adverse event was reported 1417 times

These drugs are most commonly taken by patients reporting ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE:

# Drug Count
0 METHOTREXATE SODIUM 1307
1 LEFLUNOMIDE 1247
2 ETANERCEPT 1242
3 METHOTREXATE 1231
4 ADALIMUMAB 1225
5 TOCILIZUMAB 1183
6 INFLIXIMAB 1132
7 HYDROXYCHLOROQUINE SULFATE 1119
8 CERTOLIZUMAB PEGOL 1114
9 TOFACITINIB 1032
See all common drugs associated with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 103 0.5228
1 PSEUDOEPHEDRINE HCL 636 0.1952
2 CETIRIZINE HCL, PSEUDOEPHEDRINE HCL 61 0.1723
3 CORTISONE ACETATE 684 0.1643
4 DESOXIMETASONE 863 0.1471
5 CAFFEINE CITRATE 82 0.1329
6 SARILUMAB 565 0.0849
7 ALCOHOL PREP PADS 8 0.0816
8 CETIRIZINE HYDROCHLORIDE TABLETS 697 0.0762
9 PSEUDOEPHEDRINE HYDROCHLORIDE 593 0.0683
See all drugs enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-6 Receptor Antagonist [EPC] 1196 0.0173
1 Antirheumatic Agent [EPC] 1247 0.0173
2 Aminosalicylate [EPC] 1031 0.0130
3 Selective T Cell Costimulation Modulator [EPC] 1025 0.0123
4 Interleukin-12 Antagonist [EPC] 532 0.0091
5 Interleukin-23 Antagonist [EPC] 532 0.0081
6 Prostaglandin E1 Analog [EPC] 110 0.0079
7 CD20-directed Cytolytic Antibody [EPC] 1002 0.0072
8 Interleukin-1 Receptor Antagonist [EPC] 58 0.0062
9 Vitamin D [EPC] 942 0.0054
See all drug classes enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE